BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,288,961 | +128.8% | 13,974 | +24.6% | 0.04% | +104.8% |
| Q3 2023 | $563,418 | -18.2% | 11,219 | +2.9% | 0.02% | -16.0% |
| Q2 2023 | $688,943 | +41.1% | 10,901 | +0.5% | 0.02% | +31.6% |
| Q1 2023 | $488,096 | +149622.7% | 10,849 | +45.7% | 0.02% | +35.7% |
| Q4 2022 | $326 | -99.9% | 7,444 | +0.3% | 0.01% | -36.4% |
| Q3 2022 | $489,000 | +27.0% | 7,420 | -2.6% | 0.02% | +37.5% |
| Q2 2022 | $385,000 | -20.9% | 7,618 | 0.0% | 0.02% | -5.9% |
| Q1 2022 | $487,000 | -40.3% | 7,618 | 0.0% | 0.02% | -37.0% |
| Q4 2021 | $816,000 | +76.2% | 7,618 | +69.2% | 0.03% | +58.8% |
| Q3 2021 | $463,000 | – | 4,503 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |